Furiex Pharmaceuticals, Inc. — key financial figures for fiscal year 2013 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2013)

$71.0M

Net Income/Loss (FY2013)

-$29.7M

Total Assets (FY2013)

$88.4M

Total Equity (FY2013)

$18.4M

Cash Flows from Operating Activities (FY2013)

-$23.1M

Source: Furiex Pharmaceuticals, Inc. 10-K filing (FY2013). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.